首页 >
法规速递
-
Page: CHMP opinions on consultation procedures-2025/11/3
2025-11-04查看详情 > -
Document: CAT quarterly highlights and approved ATMPs - December 2025-2025/12/2
2025-12-03查看详情 > -
Document: List of signals discussed at PRAC since September 2012-2026/1/6
2026-01-07查看详情 > -
Document: List of eligible industry stakeholder organisations-2026/2/10
2026-02-11查看详情 > -
Document: Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI) - ATMP-2026/3/19
2026-03-20查看详情 > -
Page: Referentials Management Service (RMS)-20256/4/23
2026-04-24查看详情 > -
Document: Timetable: Non-safety referrals-2026/6/4
2026-06-05查看详情 > -
Document: Questions and answers on Article 20 non-pharmacovigilance procedures-2026/7/16
2026-07-17查看详情 > -
国家药监局关于启用生物制品批签发电子证明、麻醉药品和精神药品实验研究立项电子批件的公告（2022年第84号）-2022/10/11
2022-11-14查看详情 > -
Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting Viral Pathogens(Draft)-2023/03/01
2023-03-01查看详情 >
